Oncol Rep 34: 1146-1152, 2015; DOI: 10.3892/or.2015.4074
After the publication of the article, the authors decided to add an Acknowledgements section:
Acknowledgements
Research activity leading to the results shown in the paper is the continuation of the IMI Predect program that received support from the Innovative Medicines initiative Joint Undertaking under grant agreement no. 115188, resources of which are composed of financial contribution from the European Union's Seventh Framework Programme (FP7/2007-2013) and EFPIA companies in kind contribution. Present results and conclusions are not endorsed by the Predect Consortium.